Clinuvel Pharmaceuticals Ltd ADR (CLVLY)
Clinuvel Pharmaceuticals Ltd ADR is a depositary receipt representing common stock of Clinuvel Pharmaceuticals Limited, a biopharmaceutical company listed on OTC Markets. The underlying company develops and commercializes treatments for patients with genetic, metabolic, systemic, and life-threatening disorders across Australia, Europe, the United States, Switzerland, and other international markets. Its lead product candidate is SCENESSE, a systemic photoprotective drug for preventing phototoxicity in adults with erythropoietic protoporphyria (EPP). The company also advances a pipeline that includes CUV9900, PR
Stock Summary
Fair Value
Profitability & Growth
Quality & Risk
Events & Dividends
Technical Outlook
FAQ
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
